质谱技术在临床化学中用于骨髓瘤检测的发展历程 - Suppr

Suppr

超能文献

Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.

作者信息

Murray David L, Willrich Maria A V

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

出版信息

J Appl Lab Med. 2019 Nov;4(3):474-476. doi: 10.1373/jalm.2018.028902.

DOI:10.1373/jalm.2018.028902

PMID:31659091

Abstract

摘要

相似文献

Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.

J Appl Lab Med. 2019 Nov;4(3):474-476. doi: 10.1373/jalm.2018.028902.

Trade-offs in mass spectrometry.

Clin Chem. 1997 Jun;43(6 Pt 1):915.

Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics.

Clin Lab Med. 2018 Sep;38(3):487-497. doi: 10.1016/j.cll.2018.05.001. Epub 2018 Jul 20.

Prospects for mass spectrometry in clinical chemistry.

Ann Clin Biochem. 1975 Mar;12(2):51-7. doi: 10.1177/000456327501200118.

Tandem mass spectrometry in the clinical chemistry laboratory.

Clin Biochem. 2003 Sep;36(6):471-81. doi: 10.1016/s0009-9120(03)00105-x.

Kinetic error on Kodak Ektachem: a clue in diagnosis of myeloma.

Clin Chem. 1994 Jan;40(1):166-7.

Preface.

Adv Clin Chem. 2019;89:xi. doi: 10.1016/S0065-2423(19)30014-9.

Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies.

J Proteome Res. 2018 Mar 2;17(3):1326-1333. doi: 10.1021/acs.jproteome.7b00890. Epub 2018 Feb 15.

Evaluation of linearity in the clinical laboratory.

Arch Pathol Lab Med. 2004 Oct;128(10):1078; author reply 1078. doi: 10.5858/2004-128-1078b-IR.

Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease.

Semin Hematol. 2018 Jan;55(1):41-43. doi: 10.1053/j.seminhematol.2018.02.008. Epub 2018 Feb 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.

J Appl Lab Med. 2019 Nov;4(3):474-476. doi: 10.1373/jalm.2018.028902.

Trade-offs in mass spectrometry.

Clin Chem. 1997 Jun;43(6 Pt 1):915.

Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics.

Clin Lab Med. 2018 Sep;38(3):487-497. doi: 10.1016/j.cll.2018.05.001. Epub 2018 Jul 20.

Prospects for mass spectrometry in clinical chemistry.

Ann Clin Biochem. 1975 Mar;12(2):51-7. doi: 10.1177/000456327501200118.

Tandem mass spectrometry in the clinical chemistry laboratory.

Clin Biochem. 2003 Sep;36(6):471-81. doi: 10.1016/s0009-9120(03)00105-x.

Kinetic error on Kodak Ektachem: a clue in diagnosis of myeloma.

Clin Chem. 1994 Jan;40(1):166-7.

Preface.

Adv Clin Chem. 2019;89:xi. doi: 10.1016/S0065-2423(19)30014-9.

Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies.

J Proteome Res. 2018 Mar 2;17(3):1326-1333. doi: 10.1021/acs.jproteome.7b00890. Epub 2018 Feb 15.

Evaluation of linearity in the clinical laboratory.

Arch Pathol Lab Med. 2004 Oct;128(10):1078; author reply 1078. doi: 10.5858/2004-128-1078b-IR.

Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease.

Semin Hematol. 2018 Jan;55(1):41-43. doi: 10.1053/j.seminhematol.2018.02.008. Epub 2018 Feb 26.